Vireo Growth (VREOF) Convertible Debt (2023 - 2026)
Vireo Growth (VREOF) posted Convertible Debt of $8.3 million for Q1 2026, down 3.49% sequentially from $8.6 million in Q4 2025, and down 15.95% YoY from $9.9 million in Q1 2025.
Vireo Growth (VREOF) Convertible Debt (2023 - 2026) Analysis & Trends
Vireo Growth has reported Convertible Debt for 4 years, with the latest figure at $8.3 million in Q1 2026.
- Quarterly Convertible Debt fell 15.95% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (down 15.95% YoY) and the FY2025 annual result came in at $8.6 million, down 13.13% from the prior year.
- Convertible Debt retreated to $8.3 million in Q1 2026 per VREOF's latest filing, from $8.6 million in the prior quarter.
- Over five years, Convertible Debt peaked at $9.9 million in Q4 2024 and troughed at $3.1 million in Q2 2023.
- A 4-year average of $8.3 million and a median of $9.1 million in 2023 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2024 and 2026: Convertible Debt soared 213.02% in 2024, then fell 15.95% in 2026.
- Over 4 years, Convertible Debt stood at $9.1 million in 2023, then grew by 8.31% to $9.9 million in 2024, then fell by 13.13% to $8.6 million in 2025, then slipped by 3.49% to $8.3 million in 2026.
- According to Business Quant data, Convertible Debt over the past three periods registered $8.3 million, $8.6 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Vireo Growth | 482.88 Mn | 340.58 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.30 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Sep 30, 2025 | 8.25 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 9.90 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | 9.41 Mn |
| Dec 31, 2023 | 9.14 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 3.09 Mn |